BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33260951)

  • 1. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
    Sankaranarayanan R; Kumar DR; Altinoz MA; Bhat GJ
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
    Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.
    Patrono C
    J Am Coll Cardiol; 2015 Jul; 66(1):74-85. PubMed ID: 26139061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
    Podhorec J; Hrstka R; Bílek O; Tuček Š; Navrátil J; Michalová E; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):77-81. PubMed ID: 31023028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and the prevention of colorectal cancer.
    Ferrández A; Piazuelo E; Castells A
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
    Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
    Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis.
    Din FV; Dunlop MG; Stark LA
    Br J Cancer; 2004 Jul; 91(2):381-8. PubMed ID: 15188000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
    Rao M; Yang W; Seifalian AM; Winslet MC
    Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 inhibition and colorectal cancer.
    Koehne CH; Dubois RN
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):12-21. PubMed ID: 15252926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 inhibition in clinical cancer prevention.
    Lynch PM
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):21-6. PubMed ID: 11301836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
    Chell S; Kaidi A; Williams AC; Paraskeva C
    Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
    Masmoudi A; Chevalier TL; Sabatier L; Soria JC
    Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets of aspirin and cancer prevention.
    Alfonso L; Ai G; Spitale RC; Bhat GJ
    Br J Cancer; 2014 Jul; 111(1):61-7. PubMed ID: 24874482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin in the Prevention of Colorectal Neoplasia.
    Drew DA; Chan AT
    Annu Rev Med; 2021 Jan; 72():415-430. PubMed ID: 33035431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of aspirin as a chemopreventive agent.
    Dovizio M; Bruno A; Tacconelli S; Patrignani P
    Recent Results Cancer Res; 2013; 191():39-65. PubMed ID: 22893199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.